Fabry Disease with Aseptic Meningitis: A Case Series and Literature Review of an Underestimated Clinical Presentation

Abstract

Objective

Fabry disease (FD) is an X-linked lysosomal storage disease caused by the mutation in the α-galactosidase A gene that leads to a consequently decreased α-galactosidase A enzyme activity and a series of clinical presentations. However, FD accompanied with aseptic meningitis can be relatively scarce and rarely reported, which leads to significant clinical misdiagnosis of this disease.

Methods

Sixteen patients diagnosed with FD based on a decreased activity of α-galactosidase A enzyme and/or genetic screening were identified through a 6-year retrospective chart review of a tertiary hospital. Clinical presentations, brain magnetic resonance imaging, cerebrospinal fluid analysis, treatment and outcome data were analyzed in cases of aseptic meningitis associated with FD.

Results

Three out of 16 cases exhibited aseptic meningitis associated with FD. There was one female and two male patients with a mean age of 33.3 years. A family history of renal failure or hypertrophic cardiomyopathy was found in 3 cases. All cases presented with a persistent or intermittent headache and recurrent ischemic stroke. The cerebrospinal fluid analyses showed mild pleocytosis in 2 patients and an elevated level of protein in all patients. Cerebrospinal fluid cytology revealed activated lymphocytes, suggesting the existence of aseptic meningitis. In the literature review, up to 9 cases presenting with FD and aseptic meningitis were found, which bore a resemblance to our patients in demographic and clinical characteristics.

Conclusion

Our cases suggested that aseptic meningitis in FD might be under-detected and easily misdiagnosed, and should be more thoroughly examined in further cases.

Keywords

Fabry disease / aseptic meningitis / ischemic stroke / headache / case series

References

[1] BoustanyRMN. Lysosomal storage diseases—the horizon expands. Nat Rev Neurol, 2013, 9(10): 583-598

[2] DubostJJ, ViallardIL, SauvezieB. Chronic meningitis in Fabry’s disease. J Neurol Neurosurg Psychiatry, 1985, 48(7): 714-715

[3] UyamaE, UenoN, UchinoM, et al.. Headache Associated With Aseptic Meningeal Reaction as Clinical Onset of Fabry’s Disease. Headache, 1995, 35(8): 498-501

[4] PerrotX, NighoghossianN, DerexL, et al.. Vertebro-basilar ischemic strokes and aseptic meningitis, late complications of Fabry’s disease. Rev Neurol (Paris, French), 2002, 158(5): 596-598Pt 1

[5] CallegaroD, Kaimen-MacielDR. Fabry’s disease as a differential diagnosis of MS. Int MS J, 2006, 13(1): 27-30

[6] SchreiberW, UdvardiA, KristoferitschW. Chronic meningitis and lacunar stroke in Fabry disease. J Neurol, 2007, 254(10): 1447-1449

[7] LidoveO, ChauveheidMP, BenoistL, et al.. Chronic meningitis and thalamic involvement in a woman: Fabry disease expanding phenotype. J Neurol Neurosurg Psychiatry, 2007, 78(9): 1007

[8] LidoveO, ChauveheidMP, CaillaudC, et al.. Aseptic meningitis and ischaemic stroke in Fabry disease: Aseptic meningitis in Fabry disease. Int J Clin Pract, 2009, 63(11): 1663-1667

[9] SawadaJ, KatayamaT, KanoK, et al.. A Sporadic Case of Fabry Disease Involving Repeated Fever, Psychiatric Symptoms, Headache, and Ischemic Stroke in an Adult Japanese Woman. Intern Med, 2015, 54(23): 3069-3074

[10] ZarateYA, HopkinRJ. Fabry’s disease. Lancet, 2008, 372(9647): 1427-1435

[11] SchiffmannR, RiesM. Fabry Disease: A Disorder of Childhood Onset. Pediat Neurol, 2016, 64: 10-20

[12] RozenfeldP, FeriozziS. Contribution of inflammatory pathways to Fabry disease pathogenesis. Mol Genet Metab, 2017, 122(3): 19-27

[13] RiganteD, CipollaC, BasileU, et al.. Overview of immune abnormalities in lysosomal storage disorders. Immunol Lett, 2017, 188: 79-85

[14] DeGrabaT, AzharS, Dignat-GeorgeF, et al.. Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol, 2000, 47(2): 229-233

[15] El-AbassiR, SinghalD, EnglandJD. Fabry’s disease. J Neurol Sci, 2014, 344(1–2): 5-19

[16] DubucV, MooreDF, GioiaLC, et al.. Prevalence of Fabry Disease in Young Patients with Cryptogenic Ischemic Stroke. J Stroke Cerebrovasc Dis, 2013, 22(8): 1288-1292